{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:45:52Z","timestamp":1776570352462,"version":"3.51.2"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170897"],"award-info":[{"award-number":["32170897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.celrep.2024.114249","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T18:53:23Z","timestamp":1715885603000},"page":"114249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Podocyte SIRP\u03b1 reduction aggravates lupus nephritis via promoting T cell inflammatory responses"],"prefix":"10.1016","volume":"43","author":[{"given":"Bin","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dihan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-9845","authenticated-orcid":false,"given":"Limin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114249_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celrep.2024.114249_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.celrep.2024.114249_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-010-8207-1","article-title":"Histopathology of lupus nephritis","volume":"40","author":"Giannakakis","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.ackd.2019.08.011","article-title":"Lupus Podocytopathy: An Overview","volume":"26","author":"Oliva-Damaso","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.celrep.2024.114249_bib5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/jcm8091340","article-title":"Podocyte Injury in Lupus Nephritis","volume":"8","author":"Sakhi","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.celrep.2024.114249_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41581-019-0232-6","article-title":"Design and application of single-cell RNA sequencing to study kidney immune cells in lupus\u00a0nephritis","volume":"16","author":"Rao","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.celrep.2024.114249_bib7","doi-asserted-by":"crossref","first-page":"103134","DOI":"10.1016\/j.autrev.2022.103134","article-title":"New insights for regulatory T\u00a0cell in lupus nephritis","volume":"21","author":"Li","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.celrep.2024.114249_bib8","first-page":"e30330","article-title":"An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.celrep.2024.114249_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/BOR.0000000000000578","article-title":"The immune podocyte","volume":"31","author":"Bhargava","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.celrep.2024.114249_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP family of receptors and immune regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib11","first-page":"637","article-title":"Myelomeningocele: comprehensive treatment","volume":"70","author":"Alexander","year":"1989","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.celrep.2024.114249_bib12","first-page":"355","article-title":"[Posterior urethral valve and urinary ascites]","volume":"22","author":"Ohba","year":"1977","journal-title":"Rinsho Hoshasen."},{"key":"10.1016\/j.celrep.2024.114249_bib13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.103.5.1426","article-title":"Bronchial carcinoid tumors in pediatric patients","volume":"103","author":"Wang","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.celrep.2024.114249_bib14","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00571.2009","article-title":"SIRP-alpha-CD47 system functions as an intercellular signal in the renal glomerulus","volume":"299","author":"Kurihara","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.celrep.2024.114249_bib15","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1742-4658.2012.08682.x","article-title":"SIRPalpha interacts with nephrin at the podocyte slit diaphragm","volume":"279","author":"Kajiho","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.celrep.2024.114249_bib16","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00597.2012","article-title":"SIRPalpha signaling regulates podocyte structure and function","volume":"305","author":"Takahashi","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.celrep.2024.114249_bib17","doi-asserted-by":"crossref","first-page":"e124747","DOI":"10.1172\/jci.insight.124747","article-title":"Signal regulatory protein alpha protects podocytes through promoting autophagic activity","volume":"5","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2024.114249_bib18","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1172\/JCI99507","article-title":"CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease","volume":"128","author":"Maeda","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.114249_bib19","doi-asserted-by":"crossref","first-page":"102980","DOI":"10.1016\/j.autrev.2021.102980","article-title":"Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis","volume":"20","author":"Jamaly","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.celrep.2024.114249_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.5508","article-title":"Podocytes present antigen to activate specific T\u00a0cell immune responses in inflammatory renal disease","volume":"252","author":"Li","year":"2020","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.celrep.2024.114249_bib21","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00359.2018","article-title":"Podocyte-specific expression of Cre recombinase promotes glomerular basement membrane thickening","volume":"316","author":"Balkawade","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.celrep.2024.114249_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/RHU.0b013e3182a6a924","article-title":"Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus","volume":"19","author":"Smith","year":"2013","journal-title":"J.\u00a0Clin. Rheumatol."},{"key":"10.1016\/j.celrep.2024.114249_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2008.12.001","article-title":"Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway","volume":"19","author":"Matozaki","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.celrep.2024.114249_bib24","doi-asserted-by":"crossref","first-page":"576310","DOI":"10.3389\/fimmu.2020.576310","article-title":"Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity","volume":"11","author":"Myers","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4049\/jimmunol.165.3.1344","article-title":"Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein\/SH2 domain leukocyte protein of 65\u00a0kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells","volume":"165","author":"Mizuno","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib26","first-page":"245","article-title":"Two-floor TLC as a routine analytical tool in forensic chemistry","volume":"16","author":"Maiti","year":"1971","journal-title":"J.\u00a0Forensic Sci."},{"key":"10.1016\/j.celrep.2024.114249_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjh.15552","article-title":"An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma","volume":"184","author":"Andorsky","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.celrep.2024.114249_bib28","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2014-08-595934","article-title":"An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia","volume":"125","author":"Sharman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114249_bib29","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.celrep.2024.114249_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00964-19","article-title":"mSphere of Influence: It's Not Me, It's You-How Donor Factors Influence Kidney Transplant Outcomes","volume":"5","author":"Pastrana","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.celrep.2024.114249_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.celrep.2024.114249_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0961203310389100","article-title":"IL-17-producing T\u00a0cells in lupus nephritis","volume":"20","author":"Apostolidis","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.celrep.2024.114249_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/1744666X.2019.1593141","article-title":"The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target","volume":"15","author":"Koga","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib36","doi-asserted-by":"crossref","first-page":"624971","DOI":"10.3389\/fimmu.2020.624971","article-title":"Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus","volume":"11","author":"Koga","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRPalpha Immune Checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.114249_bib38","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41467-021-23442-z","article-title":"Intratumoral SIRPalpha-deficient macrophages activate tumor antigen-specific cytotoxic T\u00a0cells under radiotherapy","volume":"12","author":"Bian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114249_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.114249_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114249_bib41","doi-asserted-by":"crossref","first-page":"E5434","DOI":"10.1073\/pnas.1521069113","article-title":"Cd47-Sirpalpha interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells","volume":"113","author":"Bian","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.celrep.2024.114249_bib42","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/j.clml.2018.05.022","article-title":"An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma","volume":"18","author":"Burke","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.celrep.2024.114249_bib43","doi-asserted-by":"crossref","first-page":"110331","DOI":"10.1016\/j.cellsig.2022.110331","article-title":"SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies","volume":"94","author":"Leveille","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.celrep.2024.114249_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2177\/jsci.35.56","article-title":"[Involvement of Syk in pathology of systemic autoimmune disease]","volume":"35","author":"Iwata","year":"2012","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.celrep.2024.114249_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2017.145","article-title":"SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"31","author":"Mutzbauer","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2024.114249_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bcp.14962","article-title":"Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia","volume":"88","author":"Lam","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.celrep.2024.114249_bib47","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1074\/jbc.271.9.4755","article-title":"Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine","volume":"271","author":"Peters","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2024.114249_bib48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.188.5.819","article-title":"Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation","volume":"188","author":"Lankar","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.114249_bib49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4049\/jimmunol.170.2.846","article-title":"A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation","volume":"170","author":"Sedlik","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41419-019-1587-0","article-title":"R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2024.114249_bib51","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2011.137","article-title":"Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis","volume":"91","author":"Ryan","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.celrep.2024.114249_bib52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-023-01049-2","article-title":"B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation","volume":"20","author":"Ma","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41927-021-00178-3","article-title":"Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis","volume":"5","author":"Pohlmeyer","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.celrep.2024.114249_bib54","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1016\/j.bmc.2010.06.083","article-title":"Phenolic constituents isolated from Fragaria ananassa Duch. inhibit antigen-stimulated degranulation through direct inhibition of spleen tyrosine kinase activation","volume":"18","author":"Ninomiya","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.celrep.2024.114249_bib55","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1038\/s41598-020-70540-x","article-title":"Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis","volume":"10","author":"Tang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2024.114249_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/0886022X.2020.1764854","article-title":"miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-beta1\/Smad3 signaling pathway","volume":"42","author":"Liu","year":"2020","journal-title":"Ren. Fail."},{"key":"10.1016\/j.celrep.2024.114249_bib57","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.yexcr.2012.05.016","article-title":"Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-beta1 up-regulation in proximal tubular epithelial cells","volume":"318","author":"Yang","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.celrep.2024.114249_bib58","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40265-018-0927-1","article-title":"Fostamatinib: First Global Approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.celrep.2024.114249_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.semnephrol.2018.05.019","article-title":"Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy","volume":"38","author":"McAdoo","year":"2018","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.celrep.2024.114249_bib60","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.1102603","article-title":"Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients","volume":"189","author":"Kim","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.114249_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","article-title":"Targeting interferons and their pathways in systemic lupus erythematosus","volume":"17","author":"Chasset","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.celrep.2024.114249_bib62","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jm500228a","article-title":"Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase","volume":"57","author":"Currie","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.celrep.2024.114249_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.celrep.2024.114249_bib64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.celrep.2024.114249_bib65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1681\/ASN.2015060672","article-title":"Kruppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers","volume":"28","author":"Mallipattu","year":"2017","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.celrep.2024.114249_bib66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2024.114249_bib67","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.23758","article-title":"Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis","volume":"58","author":"Nile","year":"2008","journal-title":"Arthritis Rheum."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724005771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724005771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:30:56Z","timestamp":1754368256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724005771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2211124724005771"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114249","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Podocyte SIRP\u03b1 reduction aggravates lupus nephritis via promoting T cell inflammatory responses","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114249"}}